New disease? No problem. Regenstrief has new codes to help sort through COVID-19
The codes are critical to help track the virus by allowing health systems and public health officials around the world seamlessly exchange information.
The codes are critical to help track the virus by allowing health systems and public health officials around the world seamlessly exchange information.
Some are asking whether coronavirus aid funds are flowing to the neediest hospitals, or to those that already have deep financial resources, as the money is doled out to thousands of institutions nationwide.
The increase is hitting more young people. People under 30 now account for 22% of all who have tested positive for COVID-19 in Indiana, up from 15% just a few weeks ago.
In Touch Pharmaceuticals serves long-term-care facilities in Illinois, Indiana and Michigan. It credits its system for helping clients reduce medication errors, cut waste and reduce costs.
West Lafayette-based Bioanalytical Systems’ latest executive departure comes amid recent signs of stability, turnaround and growth for a company that just three years ago was on the verge of sinking.
Aarti Shah oversees Lilly’s global information technology, information security, advanced analytics and data sciences, and digital health.
The Hoosier state has 17,093 industry jobs spread out among 69 companies, from Indianapolis-based drugmaker Eli Lilly and Co. to startups scattered around the state, but mostly in clusters near research universities.
Telemedicine is a $21 billion worldwide industry that has long promised to overhaul health care but struggled as recently as six months ago to get steady traction.
The Greenfield-based company, which spun off from Eli Lilly and Co. in 2018, said it expects the deal to close in early August.
Much of routine health care came to a halt in March as hospitals cleared space for an expected wave of COVID-19 patients and authorities ordered a halt to surgeries and other procedures that could be postponed.
The Indianapolis drugmaker also said it expects to begin dosing patients in a complementary clinical study in the U.S. in the coming days.
The Indianapolis-based insurer says the treatments are “investigational”—or still under clinical study—but a California woman claims the electrical stimulation is FDA-approved and supported by numerous studies.
Taltz rang up sales of $1.3 billion last year, an increase of 46%, making it Lilly’s fastest-growing drug. An estimated 137,000 patients have been treated with Taltz worldwide since its launch four years ago.
Philip and Martin Low’s latest venture, Eradivir, was incorporated in February to develop a treatment that would fight the influenza virus, but COVID-19 prompted a tweak to the business plan.
Around the world, more than 80 vaccine projects are under development by pharmaceutical companies and university research laboratories.
The not-for-profit and its health research are a testament to the idea that all innovation is related—even when the connection appears tenuous at first glance.
The company is one of many across the globe in a mad rush to develop radioligand therapies for cancer treatment—a field that’s expected to see explosive growth.
The Indiana Donor Network Organ and Tissue Recovery Center has re-tasked two operating rooms and an intensive care unit to recover major organs, such as the kidneys, heart and lungs.
Washington, D.C.-area-based Maximus is taking on a critical, massive assignment: helping health departments across Indiana contact people who have tested positive for COVID-19 to learn whom they might have exposed.
The IUPUI nursing professor is co-leading a study on health behaviors and health outcomes during the pandemic.